Recent studies have identified overexpression of TIMM8A and TIMM13 in various tumor types, including breast cancer [14–17], endometrial carcinoma [17], osteosarcoma [18], and cutaneous melanoma [19]. Here, TIMM8A is linked to endometrial carcinoma.